[1]
J. H. Hoffmann, C. Knoop, K. Schäkel, A. H. Enk, and E. N. Hadaschik, “Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio­markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles”, Acta Derm Venereol, vol. 101, no. 5, p. adv00462, May 2021.